Prostate Cancer
From the gene to the clinic: prostate cancer death can now be an exception?
Published in Cancer Gene Therapy Week, December 15th, 2003
"The most significant discovery of the second half of the 20th century in the field of prostate cancer therapy is probably the observation that the human prostate, as well as many other peripheral human tissues, synthesize locally an important amount of androgens from the inactive steroid precursors dehydroepiandrosterone (DHEA) and its sulfate DHEA-S," scientists in Canada report.
"In parallel with these observations, two important discoveries also made by our group are applied in the clinic worldwide, namely the use of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Gene Therapy Week
More Articles from Cancer Gene Therapy Week
- Melanoma
Interferons are potent stimulators of interferon-alpha inducible genes - Oncology
ONYX-015-based replicating adenoviruses can deliver prodrug converting enzyme - Drug Development
A new fusion gene causes direct and bystander killing of sarcomas - Drug Resistance
Targeted gene therapies could exploit or overcome tumor hypoxia - Acute Myeloid Leukemia
Progenitor cell involvement predicts response to induction chemotherapy in AML - Antitumor Agent
TT-232: a somatostatin structural derivative as a potent antitumor drug - More from this issue of Cancer Gene Therapy Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
